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Abstract 
Allosteric regulation plays an important role in many biological processes, such as signal 
transduction, transcriptional regulation and metabolism. Allostery is rooted in the 
fundamental physical properties of macromolecular systems, but its underlying 
mechanisms are still poorly understood.  A collection of contributions to a recent 
interdisciplinary CECAM (Centre Européen de Calcul Atomique et Moléculaire) workshop is 
used here to provide an overview of the progress and remaining limitations in the 
understanding of the mechanistic foundations of allostery gained from computational and 
experimental analyses of real proteins systems and model systems. The main conceptual 
frameworks instrumental in driving the field are discussed. We illustrate the role of these 
frameworks in illuminating molecular mechanisms and explaining cellular processes, and 
describe some of their promising practical applications in engineering molecular sensors 
and informing drug design efforts.   
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Introduction 
Allostery refers to processes whereby a binding event at one site of a biological 
macromolecule affects the binding activity at another distinct functional site, enabling the 
regulation of the corresponding function. Since its initial formulations over 50 years ago 
(Changeux, 1961, 2011; Koshland et al., 1966; Monod and Jacob, 1961; Monod et al., 
1965), allosteric regulation has been recognized as playing a key role in many biological 
processes, most prominently in signal transduction (Changeux, 2012; Changeux and 
Edelstein, 2005; Falke and Piasta, 2014; Nussinov et al., 2013), molecular machine 
function (Saibil, 2013), transcriptional regulation (Li et al., 2017; Wright and Dyson, 2015), 
and metabolism (Link et al., 2014).  Allostery is rooted in the fundamental physical 
properties of macromolecular systems, and probably of other materials as well. However, 
the detailed mechanisms whereby these physical properties underpin allostery are not fully 
understood. Furthermore, allosteric effects are modulated by the cellular context in both 
health and disease.  
 
Computational approaches have all along played an important role in the investigation of 
allosteric mechanisms. They have provided insights into some of the underpinnings of 
allostery (Dokholyan, 2016; Guo and Zhou, 2016; Schueler-Furman and Wodak, 2016) and 
have recently shown great promise in various practical applications, such as engineering 
regulatory modules in proteins and identifying allosteric binding sites that can be targeted 
by specific drugs. Notable examples of the latter application include re-sensitizing resistant 
hepatitis C variants by a combination therapy that involves binding to the allosteric site of 
NS5A (Sun et al., 2015), allosteric inhibitors of HIV integrase (Hayouka et al., 2007), or the 
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discovery of allosteric drugs that inhibit PARP-1 without hampering its action in cancer-
related DNA repair deficiencies (Steffen et al., 2014).  
 
One should also mention various recent bioinformatics approaches, which analyse 
sequence information (patterns of sequence conservation or correlated mutations) with the 
goal of uncovering signals of evolutionary pressure that may either inform or validate 
mechanistic aspects of allosteric processes (Dima and Thirumalai, 2006; Kass and 
Horovitz, 2002; Livesay et al., 2012; Lockless and Ranganathan, 1999; May et al., 2007).  
Here, too, the vast increase in available data on protein sequences from different 
organisms and massive data on human polymorphism derived from next generation 
sequencing efforts (Clarke et al., 2016) is providing unprecedented (and still largely 
untapped) opportunities for investigating the role of evolution in shaping allosteric 
regulation. 
 
A recent CECAM (Centre Européen de Calcul Atomique et Moléculaire) workshop brought 
together about 30 computational biophysicists, protein modellers and bioinformaticians as 
well as experimentalists for an inspiring 2.5 days of stimulating talks and discussions. 
Among the important topics addressed were the new insights gained into the mechanistic 
foundations of allostery from computational and experimental analyses of real protein 
systems, as well as from very simple in silico toy materials.  Also presented were 
informative examples describing how allostery enables information processing in cellular 
signalling cascades. Real excitement was generated by reports on the rational design of 
allosteric systems that can be modulated to produce desired activity and cellular behaviour, 
or engineered to act as sensitive molecular sensors. Encouraging results were also 
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described on the rational discovery of allosteric drugs by combining computational and 
experimental approaches. 
 
In the following we summarize the highlights of the meeting. Further details are provided in 
the Supplementary Material. 
 
Mechanistic underpinnings of allostery: insights from computational and 
experimental approaches. 
The current understanding of allosteric systems has been increasingly influenced by the 
so-called ensemble model of allostery (Hilser et al., 2012; Motlagh et al., 2014), itself 
rooted in the seminal model of Monod Wyman and Changeux (MWC) (Monod et al., 1965), 
derived from studies on hemoglobin (Perutz, 1970), the ‘ancestor’ of all allosteric systems.   
According to the ensemble model, first described in the eighties (Cooper, 1984; 
Frauenfelder et al., 1988), the allosteric behavior of a macromolecular system arises from 
the properties of the native free energy landscape of the system, and how this landscape is 
remodeled by various ‘perturbations’, such as ligand binding, protonation, or interactions 
with other proteins (Dokholyan, 2016; Kern and Zuiderweg, 2003; Schueler-Furman and 
Wodak, 2016). The main parameters that determine the allosteric behavior are thus, 1) the 
relative stabilities (or populations) of all the states accessible to the system including those 
corresponding to active and inactive conformations (with respect to ligand binding for 
instance), 2) the time scales and energy barriers associated with the transitions between 
states, and 3) the binding affinities of the ligands/effectors or conditions, which may modify 
the set of dominant states, and thereby remodel the energy landscape of the system 
(Hilser et al., 2012; Motlagh et al., 2014). However, much remains unknown about these 
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important parameters. What is the role of thermodynamics, e.g. stabilizing/destabilizing 
different states of the system, versus the role of kinetics e.g. the time scales and energy 
barriers associated with the transitions between states? What are the relative contributions 
of entropy and enthalpy to the allosteric free energy?  Is there a special role in allostery for 
protein intrinsic disorder?  Are molecular machines a distinct category of allosteric 
systems? What can we learn about allostery from simple toy materials? These are some of 
the questions that the workshop set out to scrutinize. 
 
Bolhuis and Faccioli reported progress in simulation algorithms for investigating and 
sampling rare events such as those associated with protein folding or unfolding, or with 
conformational transitions between active and inactive states in some allosteric systems. 
Such events may involve high free-energy barriers and long transition times that are not 
accessible by classical molecular dynamics (MD) simulations, even with the help of 
advanced high-performance computers, and therefore require the use of specialized 
sampling techniques involving various levels of approximations (Amaro et al., 2007; 
Markwick and McCammon, 2011; Pontiggia et al., 2015; Proctor et al., 2015). 
 
The advantage of the enhanced sampling algorithms developed in the Bolhuis group is 
that they require no prior knowledge of the reaction coordinates (the main geometric 
parameters that change during the reaction process), which is usually not available. Using 
only information on the initial and final states, these algorithms generate the collection of 
trajectories that connect these two states, and employ the transition path sampling (TPS) 
algorithm (Bolhuis et al., 2002), which incorporates methods for selecting efficient moves 
along the energy landscape (Brotzakis and Bolhuis, 2016), to sample the shortest transition 
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paths across these trajectories. Those can then be scrutinized for pertinent reaction 
coordinates, and used to estimate the transition rates by evaluating the trajectory fluxes 
(Moroni et al., 2005). An example of the application of TPS to sample the light-induced 
conformational transition of the Photoactive Yellow Protein (PYP) (Vreede et al., 2010), a 
water-soluble blue-light photoreceptor from H. halophila, is illustrated in Figure 1A. All the 
path-finding methods developed by these authors are available in the OpenPathSampling 
software (Swenson et al., 2018). 
 
The self-consistent path sampling (SCPS) method of Faccioli and collaborators affords 
further reductions in computational cost, but at the price of additional approximations, 
making it possible to simulate very slow conformational transitions of very large protein 
systems, using state-of-the-art atom-based force fields. Their method is based on a set of 
self-consistent stochastic equations of motion from which reaction pathways are generated 
by an iterative procedure (Orioli et al., 2017). The method also outputs a stochastic 
estimate of the reaction coordinates, and enables estimation of the potential of mean force 
of arbitrary collective coordinates.  A variant of the SCPS methods was used to 
characterize the extremely slow conformational transition of the ~400 residues alpha1-
antitrypsin of the serpin family (Cazzolli et al., 2014).  
 
The two sampling methods, originally developed to model protein folding/unfolding 
reactions, represent important advances.  But their potential to yield reliable mechanistic 
descriptions of the conformational transitions of allosteric systems still needs confirmation. 
Such confirmations could be obtained by applying the simulation procedures to systems for 
which the allosteric transition has been characterized experimentally, thereby enabling 
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direct comparison with the results of the simulations.  
 
Stock and colleagues have done precisely that. Recent time-resolved infrared 
spectroscopy experiments on a photo switchable PDZ2 domain have indicated that the 
allosteric transition in this system occurs on multiple timescales (Buchli et al., 2013). 
Moreover, NMR relaxation experiments on the closely related PDZ3 domain revealed 
allosteric couplings between the binding pocket and the C-terminus (Petit et al., 2009). To 
gain insight into the underlying process, Stock employed exhaustive non-equilibrium 
molecular dynamics simulations to derive a time-dependent description of this transition 
(Buchenberg et al., 2017; Stock and Hamm, 2018). Results revealed that the structural and 
dynamic changes undergone by the system are highly non-linear and occur in a non-local 
fashion, in excellent agreement with the experimental data. This in turn led the authors to 
propose similarities with the process of downhill protein folding and to question the 
soundness of interpreting allosteric transitions in terms of well-defined pathways for 
propagating the conformational changes, as commonly done in the literature. 
 
The experimental and modeling work by Hilser and colleagues on proteins with intrinsically 
disordered (ID) regions also undermines a strict pathway interpretation of allosteric 
transitions.  Intrinsically disordered proteins represent a functional oddity because they lack 
stable tertiary structures, but represent nevertheless allosteric systems that play a central 
role in signaling processes (Ferreon et al., 2013; Garcia-Pino et al., 2010; Lum et al., 2012; 
Motlagh et al., 2014; Sevcsik et al., 2011). Investigating the mechanism of transcriptional 
regulation of the glucocorticoid receptor (GR), a protein involved in signaling whose 
functionally important N-terminal domain (NTD) is intrinsically disordered, the authors 
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showed that this protein is able to allosterically regulate function by simultaneously tuning 
transcriptional activation and repression (Li et al., 2017). This allosteric regulation is 
achieved by producing translational isoforms differing only in the length of the disordered 
domain and displaying different DNA-binding affinities and transcriptional activities that are 
uncorrelated to each other. Based on biophysical measurements analyzed in the 
framework of the ensemble model of allostery championed by the authors (Motlagh et al., 
2014), compelling evidence was presented that this uncorrelated behavior is enabled 
through a mechanism of ‘energetic frustration’, whereby opposing energetic couplings 
between the structured domains and the disordered regions compete to modulate the 
overall response, as illustrated in Figure 1B. 
  
Bahar reviewed approaches based on elastic network models (ENMs), which have 
demonstrated the significance of soft collective modes of motion in enabling allosteric 
regulation of protein systems (Bahar et al., 2007; Bahar et al., 2017). These approaches 
are in line with the ensemble view of allostery, but focus on conformational ensembles 
sampled by thermal fluctuations near the native state minimum of the energy landscape. 
The motions described by such ensembles can be evaluated by normal mode analysis 
(NMA) at full atomic detail (Go et al., 1983). However, the coarse-graining of the energy 
landscape with the help of ENMs permits sampling a relatively broad subspace of 
conformers and yields a unique analytical solution for the spectrum of modes for a given 
protein fold. The modes at the low frequency end of the spectrum (soft modes) are 
particularly relevant to allostery, as they are both highly cooperative and robustly defined 
by the overall architecture of the system. 
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Applying ENMs to several systems showed that the conformational changes of proteins 
elicited by ligand binding closely overlap with one or more of the soft modes accessible in 
the unbound form (Bahar et al., 2010; Tobi and Bahar, 2005), as illustrated for adenylate 
kinase (Temiz et al., 2004) (Figure 1C). The soft modes have therefore been described as 
‘paths’ in conformational space enabling the allosteric transitions (Meireles et al., 2011), 
suggesting in turn that the ability to favour such soft modes may have played a role in the 
evolutionary selection of modules and domains that lend themselves to allosteric 
regulation.  
 
McLeish presented work focusing on allosteric control enabled solely through the 
modulation of thermal fluctuations and the resulting entropy changes, induced by ligand 
binding. A feature of this mechanism, first formalized by Cooper & Dryden (1984) (Cooper 
and Dryden, 1984) and termed thermal fluctuations allostery by the author or ‘dynamic 
allostery’ elsewhere (Guo and Zhou, 2016; Kern and Zuiderweg, 2003; Schueler-Furman 
and Wodak, 2016), is that soft global modes of motion rather than more local ones are 
recruited to enable allosteric cooperativity. As seen above, such soft modes may be readily 
described by coarse-grained models like those of Bahar and co-workers (Bahar et al., 
2010) and others (Hawkins and McLeish, 2004; Zhu et al., 2011).  To further investigate 
the implications of ‘fluctuation allostery’ McLeish uses the coarsest possible toy model of a 
protein, consisting of just one (harmonic) internal degree of freedom. This simple unit, 
termed allosteron, of which a real example was described in the eighties (Onan et al., 
1983), features one or more ligand binding sites and can also oligomerize. Crucially, it 
undergoes internal fluctuations modified by the binding of each ligand (Figure 2A). The 
author demonstrates that using the classical approximation to the harmonic-oscillator 
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partition function yields reasonable estimates of the allosteric free energy between two 
ligands bound to such a system, which contain no enthalpic terms. Extensions of the 
allosteron model have been helpful in identifying the physical origin of associated 
phenomena, such as the coupling of global and local vibrational modes in dynamic 
allostery of proteins (Hawkins and McLeish, 2006), the negative cooperativity of the CAP 
(Catabolite Activator Protein) homodimer (Toncrova and McLeish, 2010), or the sequence 
of effector-binding events in allosteric multi-protein assemblies (McLeish et al., 2018). 
The important role of protein dynamics in enabling allosteric regulation was further 
highlighted by the computational studies of Palermo and McCammon, performed on the 
large multi-domain CRISPR-Cas9 system (Palermo et al., 2016, 2017a; Palermo et al., 
2017b), the centerpiece of a recently emerged transformative genome editing technology 
(Chen and Doudna, 2017). In this multi-domain system, the endonuclease Cas9 associates 
with single-guide RNAs to site-specifically recognize and cleave any DNA sequence 
bearing a Protospacer Adjacent Motif (PAM) sequence. RNA-mediated binding to this 
sequence initiates DNA association and cleavage, with the latter performed by two spatially 
distant domains of the protein, HNH and RuvC, via a concerted mechanism. From MD 
trajectories of the CRISPR-Cas9 complex bound to PAM and for its analogue crystallized 
without PAM (Palermo et al., 2017b), the authors computed the generalized correlations 
(GC), capturing both linear and non-linear correlated motions of the system. Using the GC 
coefficients as edge weights, a residue dynamic network was built from each trajectory. 
Analyzing these networks revealed tighter communication (and increased correlated 
motions) between the HNH and RuvC domains in the presence of PAM (Figure 1E). This 
led the authors to conclude that PAM binding to CRISPR-Cas9 plays a key role in 
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triggering the interdependent conformational dynamics of HNH and RuvC, likely enabling 
the concerted cleavage of the DNA strands(Palermo et al., 2018). It furthermore allowed 
the identification of residues responsible for the information relay. Mutating two of these 
residues (K775A and R905A) was shown to decrease off-target cleavage of partially 
complementary DNAs (Chen and Doudna, 2017), opening an avenue for modulating the 
activity of CRISPR-Cas9 systems. 
In their contribution to this workshop review, Nussinov and colleagues adhere to the 
ensemble model of allostery, and view allosteric regulation as resulting from perturbations 
of the inactive (or active) conformational ensembles leading to activation (or inactivation) 
via a ‘population shift’ (Gunasekaran et al., 2004; Tsai and Nussinov, 2014). They also 
acknowledge the role of dynamics, but argue against the concept of dynamic allostery 
discussed above, which involves no changes between distinct conformational states (see 
also (Kern and Zuiderweg, 2003)). In Nussinov’s view, only distinct states, corresponding 
to local minima of the native free energy landscape, can contribute to functional allostery, 
because specific functions are performed by distinct protein conformations (Nussinov and 
Tsai, 2015) as exemplified in the supplementary Figure S1.  In support of their view they 
enumerate reasons for failing to observe conformational changes in some prominent 
allosteric systems. These reasons include crystal-packing effects, non-native crystallization 
conditions, which may stabilize the inactive state or destabilize the effector-bound active 
conformation and therefore trap a state exhibiting no conformational change. Also 
mentioned are, inadequate accounting for disordered regions, ignoring synergistic effects 
between allosteric effectors, and too short molecular dynamics simulations. 
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Novel mechanistic insights into the allosteric transitions of large multi-subunit molecular 
machines were derived from the experimental work of Horovitz. The efficiency of 
molecular machines is path-dependent. Understanding how these machines work therefore 
requires characterizing the intermediate and transition states of the allosteric switch 
reaction.  In the case of ATP-consuming bio-molecular machines, which are often 
multimeric proteins, a key issue is whether they undergo concerted (Monod et al., 1965), 
sequential (Koshland et al., 1966), or probabilistic conformational changes. Horovitz 
showed how recent advances in single-molecule techniques and native mass-spectrometry 
finally made it possible to distinguishing between these models. Using these techniques 
enables quantification of the populations of co-existing states with different numbers of 
bound ligand molecules, giving rise to a particular degree of fractional saturation (Figure 
1D). Given these populations, it is possible to determine the ligand binding constants for a 
multimeric protein and thus, to infer its allosteric mechanism (Gruber and Horovitz, 2018). 
Results showed that the ATP-promoted allosteric transitions of the homo-heptameric rings 
of GroEL are concerted (Dyachenko et al., 2013). Phi-value analysis, shown to be useful 
for studying protein folding reactions, revealed two parallel pathways for the allosteric 
transition of this protein (Gruber and Horovitz, 2016). A different approach based on an 
Arrhenius analysis of ATP hydrolysis by the group II chaperonin CCT/TRiC, the eukaryotic 
homolog of GroEL, revealed that the intra-ring conformational changes in this protein 
associated with ATP hydrolysis are sequential (Gruber et al., 2017).  Structural features 
and possible evolutionary pressure that may underlie these intriguing differences between 
the two chaperonins were briefly discussed. 
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Thought-provoking investigations of the architectural principles and properties of allosteric 
materials were presented by Wyart. Considering allostery as the process whereby ligand 
binding at one site of a protein transmits a signal to a distant functional site, the authors 
investigate this process from a purely physical perspective. Among the questions that they 
set out to answer were how materials can be designed to carry mechanical information 
over long distances, or what allosteric pathways may be optimized for?  The approach 
consists in using in silico ‘evolution’ schemes to optimize elastic toy materials, two-and 
three-dimensional spring networks, for carrying out a specific ‘function’ (Flechsig, 2017; 
Rocks et al., 2017; Yan et al., 2017a; Yan et al., 2017b, 2018).  A surprising result from 
these in silico experiments is that the type of ‘function’ greatly affects the resulting 
architectures. Optimizing the networks for a geometric task, by selecting network structures 
where binding a ligand leads to a defined displacement on the other side of the network 
(‘active site’), yields networks displaying a powerful lever at the active site, where the signal 
is required (Flechsig, 2017; Rocks et al., 2017; Yan et al., 2017a; Yan et al., 2017b). This 
lever has distinctive structural properties (between those of a solid and liquid) and may 
represent a potential candidate mechanism for allosteric proteins in which motion such as 
that for opening or closing a channel is required (Figure 2B).  Completely different 
architectures evolve when the networks are optimized for cooperative binding energy 
between the allosteric and active site (Yan et al., 2017a). These evolved architectures 
feature a very soft elastic mode that extends throughout the structure. In addition, most of 
the response tends to be captured by a single normal mode, as observed in some allosteric 
proteins. Crucially, it was found that to induce cooperativity, the frequency of this mode 
must adopt moderate values, with the predicted optimal frequency depending on the linear 
size of the system. Despite the simplicity of the investigated materials, one is left with the 
	 	 16	
impression that these in silico evolution approaches should be very useful for formulating 
key questions about real allosteric systems that may be addressed experimentally.  
 
Allostery and signalling 
The allosteric behavior of proteins and protein assemblies plays a key role in signaling 
processes. Unraveling the mechanistic underpinning of this behavior should therefore lead 
to improved understanding of how signaling events are relayed and regulated, and enable 
their modulation with promising pharmaceutical avenues for targeting human disease 
(Dokholyan, 2016)  
  
Stote and Dejaegere reported findings on the mechanism of allosteric regulation of 
retinoic acid receptors (RARs), members of the nuclear receptor (NR) superfamily 
implicated in the transcriptional cascades underlying many physiological phenomena, such 
as cell differentiation and growth (Brelivet et al., 2012; Helsen and Claessens, 2014). 
Although retinoic acid has been considered the primary regulator of RARs, phosphorylation 
of the ligand-binding domain (LBD) has been shown to modulate downstream nuclear 
signaling by phosphorylation of the regulatory N-terminal domain (NTD) (Supplementary 
Figure S2). Crystallographic studies of phospho-mimetic mutations of RARg (S371E) and 
molecular dynamics simulations showed that phosphorylation of the RARg (and RARa) 
receptors of this family leads to subtle changes in the dynamic properties of the protein 
without producing significant conformational rearrangements (Chebaro et al., 2013; 
Chebaro et al., 2017). It was furthermore proposed that a conserved long alpha-helix plays 
a key role in mediating the allosteric communication between sites in these receptors and 
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likely in other members of the nuclear receptor superfamily where the long helix in question 
is well conserved. 
 
Cecchini & Changeux presented a strategy for modeling allosteric transitions in proteins. 
This strategy involves adding or removing an agonist from the binding site of an allosteric 
protein and using unbiased MD simulations to capture the spontaneous 
transition/relaxation of the system to a distinct physiological state (Supplementary Figure 
S3). The approach was applied to the pentameric ligand-gated ion channels (pLGICs), 
representing typical allosteric membrane proteins that serve as signal transducers in 
neurotransmitter-mediated intercellular communication. In these systems, the 
activation/relaxation MD protocol was used to explore the pore-closing transition or un-
gating of the prokaryotic proton-gated channel GLIC (Nury et al., 2010). Similarly, MD 
relaxation of the open form of the eukaryotic glutamate-gated ion channel, (GluCl) upon 
removal of the positive allosteric modulator ivermectin, was shown to promote partial 
closure of the ion pore through a complex quaternary mechanism involving global receptor 
twisting and a radial expansion (blooming) of the extracellular domain (Calimet et al., 
2013). A more extended relaxation of the same channel in the absence of ivermectin 
captured the full closing motion that is consistent with the ligand-free GluCl x-ray structure 
(Martin et al., 2017). Using the same approach, the gating mechanism of pLGICs was 
explored also in the forward direction (from resting to active), revealing a correlation 
between orthosteric agonist binding and ion-pore opening (Yoluk et al., 2015; Yuan et al., 
2016). The MD-based activation/relaxation protocol thus appears as a useful approach for 
exploring the allosteric transitions at atomic resolution in these large important systems, 
	 	 18	
despite its high computational costs and the fact that it collects only a limited number of 
transition events.  
 
Rational design of allosteric systems and identification of allosteric sites. 
Several approaches for the rational design of allosteric systems, allosteric switches and 
allosteric sensors, were described by Dokholyan, Berezovsky, Karanicolas, and Plaxco. 
 
Dokholyan described new optogenetic and chemogenetic tools for controlling individual 
proteins and signaling cascades in living cells (Dagliyan et al., 2017; Dagliyan et al., 2013; 
Dagliyan et al., 2016). The approach consists of using computational procedures to identify 
solvent accessible allosteric sites (Proctor et al., 2015) on a target protein and physically 
engineering naturally occurring light-sensitive or ligand-sensitive domains into these sites. 
Light or a ligand are then used to modulate structural disorder in these domains, which, in 
turn, affects the active site of the target protein, switching it between inactive (increased 
disorder) and active (less disorder) states. In the illustrated examples (Figure 3A) the small 
naturally-occurring light-sensitive LOV2 domain, and the rapamycin-responsive uniRapR 
domain, were respectively engineered into several kinases involved in cell motility 
(Dagliyan et al., 2013). Light and rapamycin were then used to respectively, inactivate and 
activate the target proteins, with the resulting effects on cell motility directly monitored by 
imaging techniques. 
 
The computational approach presented by Berezovsky quantifies the configurational work 
exerted in different parts of a protein as a result of ligand binding to a known or putative 
allosteric site and can be used to infer allosteric sites, ultimately enabling the design of 
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effector molecules (Guarnera and Berezovsky, 2016a, b).  In this approach, an 
approximation similar to those described by Bahar and McLeish is used to model the 
protein native state dynamics. The protein force field is represented by a simple Ca-based 
harmonic potential, and the presence of a ligand at the allosteric site is modeled by locally 
restraining residue pairs at the binding site. Next, the dynamics of the ligand-free and 
ligand-bound proteins are described using normal mode analysis, from which a set of 
relevant normal modes is derived. These modes are then used to evaluate the so-called 
‘allosteric potential’, defined as the mean work exerted on a residue as a result of the local 
motion of its neighbors. Lastly a per-residue “allosteric free energy” is computed from the 
difference between the ligand-free and ligand-bound conformational ensembles sampled 
by the relevant modes. Extension of the method to identify the effect of allosteric mutations 
and its application to the regulation of the activity of the insulin-degrading enzyme, 
(Guarnera and Berezovsky, 2016b; Kurochkin et al., 2017), were also mentioned. The 
extended method is implemented in the AlloSigMA,  (http://allosigma.bii.a-
star.edu.sg/home/) web-server (Guarnera et al., 2017), which can be used as a first 
approach for investigating allosteric effects on protein activity elicited by ligands or 
mutations, or for identifying potential new allosteric sites and candidates for allosteric 
mutations (Tee et al., 2018). 
 
Karanicolas, on the other hand, described a method for building molecular switches, 
which involves the chemical rescue of the active conformation of a protein.  In this 
procedure, a disruptive mutation (often of a hydrophobic residue important for protein 
stability) introduced into the protein is rescued by addition of a small molecule that 
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complements the deleted atoms.  Proof-of-concept for this approach was demonstrated by 
introducing a (deactivating) tryptophan-to-glycine mutation into an enzyme, then showing 
that activity could be restored by adding indole to complement the resulting cavity (Deckert 
et al., 2012).  The generality of this approach for building allosteric control into proteins 
other than enzymes was then explored by developing a cell-based reporter assay. This 
allowed for screening of many WG mutations to determine which would attenuate protein 
activity, and then for testing which of these mutants could subsequently be rescued using 
indole. A suite of computational and experimental methods, collectively led to the insight 
that protein structure and function were most frequently modulated indirectly through 
control of protein stability (Xia et al., 2013). Addition of indole in these allosteric cases 
served not to revert a discrete conformational change, but rather as an allosteric ligand that 
rescues activity by inducing the protein to refold to its original conformation (Budiardjo et 
al., 2016), thereby representing an excellent illustration of the ensemble model of allostery.  
 
Plaxco described how allostery and cooperativity may be leveraged to engineer a wide 
range of artificial optical, biochemical and electrochemical biosensors. Among the 
examples used to illustrate the approach was the rational design and engineering of a 
synthetic DNA-based nanodevice containing up to four interacting binding sites that can 
load and release a cargo over narrow concentration ranges, and whose affinity could be 
finely controlled via both allosteric effectors and environmental cues like pH and 
temperature (Mariottini et al., 2017). In another example, catalytic DNAzyme sequences 
(e.g. peroxidase-like DNAzymes) were combined with the consensus sequence recognized 
by specific transcription factors (either TATA binding protein or the microphthalmia-
associated transcription factor). The resulting constructs exhibited, respectively, a more 
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stable catalytically inactive conformation unable to bind the cognate transcription factor, 
and a less stable conformation competent to bind it. The presence of the transcription 
factor pushes the equilibrium between these states towards the catalytically active one, in a 
manner that can be finely controlled further by optimizing the original design (Adornetto et 
al., 2015). 
 
Kozakov presented an approach for identifying allosteric binding sites (also denoted as 
cryptic sites) in ligand-free protein structures, and predicting their drug binding potential. 
The method involves the identification of binding hotspots on the protein surface. These 
hotspots represent clusters of low energy binding poses for small organic molecular probes 
of various shapes, sizes and polarity, generated by their FTsite computational procedure 
(Ngan et al., 2012).  Applying FTsite to protein structures with known allosteric sites 
(Cimermancic et al., 2016) it was found that the ligand-free apo structures generally feature 
binding hotspots for the tested small molecular probes that are in close proximity to the 
known allosteric sites (Supplementary Figure S4). Of those, the more highly populated 
hotspot clusters (≥16 low energy poses) were deemed druggable, e.g. can be targeted by 
ligands with sufficient affinity (Kozakov et al., 2015).  The authors also reported that 
regions of protein structures close to cryptic binding sites are significantly more flexible 
than regions surrounding any other potential binding hotspots detected by their procedure 
(Beglov et al., 2018). This increased flexibility seems to be linked to missing loops or side 
chains of less reliably modeled regions of the corresponding X-ray structures, suggesting 
that such regions may be good cryptic binding site candidates. 
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Lastly, among the notable poster presentations, three reported analyses of the dynamics 
and allosteric regulations in important multi-subunit enzymes from various origins. Rivalta 
and colleagues used classical MD simulations and a community network analysis (Sethi et 
al., 2009), not unlike that of Palermo & McCammon, to elucidate the allosteric regulation in 
the imidazole glycerol phosphate synthase (IGPS) from T. maritima (Rivalta et al., 2012). 
This analysis stimulated single site mutagenesis experiments and allosteric inhibitor design 
(Rivalta et al., 2012) (Supplementary Figure S5 for details).  Gkeka and collaborators 
described potentially important findings from combined experimental and computational 
analyses on the allosteric modulation of the lipid phosphoinositide 3-kinase alpha, PI3Ka , 
which plays a pivotal role in cell proliferation and is a target for anti-cancer drug 
development (see Supplementary Figure S6 for details]. They discovered a ligand-
binding site distinct from the enzyme active site capable of inhibiting a cancer-associated 
PI3Ka mutant responsible for enzyme over activation. Ligand binding to this site was found 
to modulate the membrane binding domain of the protein, and not the active site, opening 
the avenue for designing selective inhibitors of protein-membrane interactions in this and 
other systems (Gkeka et al., 2014; Gkeka et al., 2015). Panecka-Hofman and Wade 
reported preliminary results on the dynamic allosteric coupling between distant residues of 
Pteridine reductase 1 (PTR1), a folate pathway enzyme unique to trypanosomatid 
parasites (Panecka-Hofman et al., 2017) (Supplementary Figure S7). The 4th poster 
reported progress towards gaining insight into the allosteric regulation of taste GPCRs (Di 
Pizio et al., 2016) (Supplementary Figure S8). 
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Concluding remarks 
In this collection of contributions presented at the CECAM workshop, we endeavored to 
provide an overview of the current understanding of allosteric processes and its perceived 
limitations. We also described how this still incomplete understanding is exploited more or 
less successfully to illuminate the underlying molecular mechanisms, explain cellular 
processes, design molecular sensors and inform drug design efforts.   
 
The concept of allostery has evolved significantly since the first allosteric proteins have 
been characterized (Motlagh et al., 2014; Schueler-Furman and Wodak, 2016).   We now 
have a better grasp of the important functional role of protein dynamics and, in particular, 
the role of protein intrinsic disorder. We also have more powerful computational and 
experimental tools for sampling significantly populated states of complex protein systems.  
 
Notwithstanding these advances, current computational methods are still unable to chart 
the free energy landscape of allosteric systems in an unbiased way, e.g. without prior 
knowledge of some significantly populated states of the system. Even when such 
knowledge is available, computational procedures employ various levels of approximations 
to sample the conformational transition paths between these states, as illustrated by the 
contributions of Bulhuis, Faccioli, and Stock, and work of groups employing Markov State 
Models (MSM) (Chodera and Noe, 2014; Pande et al., 2010).  Specific approaches depend 
moreover on the size and complexity of the systems under study, making it difficult to 
evaluate the information they provide about the identified transition paths. To enable such 
evaluation it would be useful to come up with a few allosteric protein systems with well-
characterized active and inactive states, to which different computational methods for 
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charting the allosteric transition paths could be applied, results compared, and eventually 
evaluated against experimental data.  
 
Particularly useful would be data derived from phi-value type analyses. Such analyses 
measure the changes in the activation energy of unfolding and the free energy of unfolding 
brought about by mutations, and those are used to characterize the transition states and 
intermediates of protein folding reactions (Fersht et al., 1992). Employing similar analyses 
to characterize the transition state of an allosteric pathway was suggested during the 
meeting, but not further elaborated on, although there have indeed been insightful 
precedents. Eaton et al. (Eaton et al., 1991) were the first to apply such analyses, generally 
referred to as rate-equilibrium linear free-energy relationships (LFERs), to allostery. Using 
pH and ligand states instead of mutations to perturb the kinetics and thermodynamics of 
the allosteric transition in hemoglobin, they showed that the transition state of the R<->T 
quaternary conformational change had closer thermodynamic properties to those of the R 
than the T conformations, validating a much earlier computational study, based on a crude 
analysis of the surface areas buried between the subunits (Janin and Wodak, 1985). A 
subsequent study of Yifrach and Horovitz (Yifrach and Horovitz, 1998) employed a genuine 
phi-value analysis, involving a limited number of mutations, to map the transition state of 
the allosteric pathway of GroEL. LFERs derived from perturbations, notably by a series of 
site-specific mutations, were used to map or the transition state of the gating reaction 
pathway of the muscle acetylcholine receptor (Grosman et al., 2000), yielding detailed 
information on the gating mechanism, described as involving a wave-like conformational 
change. 
 
	 	 25	
Computational approaches to the seemingly more tractable problem of identifying paths 
that mediate allosteric ‘communication’ between sites in a protein would also benefit from a 
more objective benchmarking. Although fundamentally different from allosteric transition 
paths on the free energy landscape, identifying communication paths also involves 
sampling the free energy landscape, but only in the vicinity of the stable ‘end’ states, and 
then quantifying the correlated motions of the corresponding conformational ensembles. 
But here too, computational procedures and the set of investigated systems tend to differ 
significantly between authors. Assessing the agreement between communication paths 
identified by different methods in the same set of allosteric systems should therefore be 
very informative. Since even in a highly structured protein ‘communication’ between sites is 
likely mediated by multiple paths (Guo et al., 2015; Taylor et al., 2016), the questions of 
whether a given path can be rigorously validated against experimental data, or whether its 
specific role can be rationalized, need to be critically evaluated. 
 
Two distinct but complementary conceptual frameworks for probing the mechanism of 
allosteric regulation, highlighted in this review, deserve special mention. One considers 
allosteric regulation as enabled by the so-called ‘soft’ modes of collective motions sampled 
by thermal fluctuations near the native state minimum, usually of highly structured protein 
systems. These soft modes are estimated computationally from experimental structures, 
using coarse-grained elastic network models (ENM), which strongly depend on the 
reference structure (usually the experimentally determined one). With skeptics, wary of 
such coarse-grained models, one would argue that ENM and the underlying conceptual 
framework have been quite instrumental not only in capturing the conformational transitions 
associated with the allosteric regulation of complex protein systems, but also in modeling 
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the entropic contributions to the allosteric free energy, and potentially for predicting 
allosteric binding sites in protein systems, as reported by several contributions to this 
review and references therein. 
 
The other conceptual framework refers to the so-called ensemble model of allostery, which 
focuses entirely on the thermodynamic analysis of the energy landscape of allosteric 
systems, including those featuring intrinsic disorder. It is thus of very broad applicability.  
As already mentioned, the main task of such analysis is quantifying the relative populations 
(stabilities) of all the states accessible to the system and how this population landscape is 
modified by ligand/effector binding, or disorder-to order transitions.   Focusing on these 
thermodynamic properties is amply justified. In many systems, the rate limiting step of the 
allosteric transition elicited by effector binding, may indeed be governed by the 
concentration (population) of the pre-existing ligand-binding competent state of a protein, 
rather than by the free energy barrier of the conformational transition it needs to undergo to 
adopt this state. As illustrated here by a number of contributions, fine-tuning the relative 
populations of the active and inactive states of protein or nucleic acid systems and the 
binding affinities of allosteric effectors, are very effective ways, by nature or in the 
laboratory, to design systems undergoing allosteric regulation of different levels of 
complexity and versatility. 
 
Clearly, allosteric regulation still needs to deliver many of its secrets. An advantage of 
allosteric regulation over regulation involving gene expression is its shorter response time 
to changing conditions. One may therefore wonder if this may determine the set of 
properties of allosteric systems, such as the existence of soft collective motions or 
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population levels of relevant states, that evolution tends to select. Are all proteins allosteric, 
as some have suggested (Gunasekaran et al., 2004)? Are molecular machines a special 
category of allosteric systems? And lastly, how much can we learn about the very 
fundamental requirements of allostery from simple toy materials?  These are only some of 
the many intriguing questions to address, going forward.     
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Figure captions 
Figure 1:  Mechanistic underpinning of allostery: insights from computations and 
experiments  
(A) Artist rendering of the conformational transitions network of the Photoactive Yellow 
Protein (PYP), the 125-residue water-soluble blue-light photoreceptor from H. halophile, 
mapped onto the energy landscape of the system using the simulation procedures of 
Bolhuis and collaborators. 
 
(B) Frustration-based allostery in the human glucocorticoid receptor (GR), an intrinsically 
disordered transcription factor analysed by Li and Hilser (Li et al., 2017).   
(I) Domain organization of the constitutively active GR constructs for translational isoforms, 
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wherein the intrinsically disordered N terminal domain (NTD) varies in length. Residues 1-
97 (red) are labeled R (for Regulatory) and residues 98-420 (grey) are labeled F (for 
Functional). Also labeled are residues corresponding to the activation function 1 core (AF1 
core) region, which is required for transcriptional activity. (II) Competing thermodynamic 
coupling in GR produces frustration. Schematic view of the thermodynamic configuration of 
GR. According to the displayed convention, the positive (+) signs between the DBD and F-
domain, and the DBD and R-domain signify they are positively coupled; stabilization of one 
domain stabilizes the other. The negative (-) sign between the R- and the F- domains 
indicate they are negatively coupled; stabilization of one domain destabilizes the other. 
 
(C) The closed conformation adenylate kinase observed upon ligand binding is sampled by 
the open form apo-structure, illustrating the work of Bahar. (I) Two experimentally resolved 
structures, unbound (left) and ligand-bound (right). (II) Conformer predicted by ENM 
(Elastic Network Model) analysis to be accessible via a soft mode to the unbound structure. 
Blue and green refer to different domains. The substrate is shown in orange spheres. 
(Adapted from (Temiz et al., 2004)). 
(D) Distributions of GroEL molecules with different numbers of bound ATP molecules at 
different ATP concentrations from the work of Horovitz and co-workers. 
 
(E) Allosteric regulation in CRISPR-Cas9, by Palermo and McCammon. (I) Dynamical 
network model of CRISPR-Cas9, identifying groups (or “communities”) of closely correlated 
residues and the strength of correlation between them before (top) and upon (bottom) PAM 
binding. (II). The allosteric path between the spatially distance HNH and RuvC domains of 
the Cas9 protein. 
 
Figure 2. Allosteric toy models and allosteric materials 
(A): Schematics of the allosteron model of McLeish, in binding (a) and self-assembly (b) 
illustrating local changes to spring constants k, and the introduction of coupling springs 
between allosteron units kc.  
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(B) Illustration of the work of Wyart and collaborators: (I) Response (black) arrows to a 
stimulus (purple arrows) in random spring network decays rapidly with distance, i.e. there is 
little action at a distance. (II) Networks can be evolved in which there is specific action at a 
distance.  Note that the response is amplified near the active site (blue arrows), indicating 
the presence of a lever in the structure. (III) Example of hinge architecture obtained while 
optimizing cooperativity, in which two parts of the material rotate around a hinge located at 
the center of the system. (IV-VI) Illustration of the cooperative architectures found: hinge 
(clothespin), shear (mint box) and twist (Rubik's cube).  
 
 
Figure 3. Rational design of allosteric systems and identification of allosteric sites. 
(A) Schematic diagrams illustrating the work of Doholyan and colleagues on optogenetic 
and chemogenetic control of target proteins using allostery and protein order-disorder 
transition, reprinted from (Dagliyan et al., 2016). 
!
(B) Illustration of the approach by involving the chemical rescue of the active conformation 
of a protein. The example shows how mutation of a buried tryptophan to glycine leads to a 
structural disruption – either through a discrete conformational change or through loss of 
protein stability – that leads to loss of protein function. Adding exogenous indole can then 
complement the cavity caused by the deleted sidechain, restoring the original protein 
conformation and, thus, its function. 
!
(C) Principle of the rational design and engineering of a synthetic DNA-based nanodevice 
described by Plaxco. Top: the designed cooperative DNA-nanodevice comprises the 
recognition element consisting of a triplex forming DNA sequence, which behaves like a 
“clamp” that binds a specific 9-base DNA ligand via the formation of both Watson-Crick and 
Hoogsteen base-pair interactions. The cooperative DNA-nanodevice is obtained by joining 
together two sequential copies of one half of such recognition element linked via a flexible 
22-base, single-stranded loop (grey portion) to two sequential copies of its other half. 
Binding of the ligand to the first receptor decreases the entropic cost associated with the 
binding to the second receptor (and thus improves its affinity for the ligand). As a result, 
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this nanodevice shows a Hill-type cooperative response, with a Hill coefficient nH = 2.1±0.1. 
Figure reproduced from (Mariottini et al., 2017). 
 
(D) Binding hotspots of small chemical probes to flexible regions of the protein tend to 
correspond to cryptic binding sites. Example from the work of Kozakov, showing the 
mapping of hotspots identified by FTsite in the unbound structure of the catalytic subunit of 
the cAMP dependent protein kinase PKA (PDB ID code 2GFC, chain A) displayed in tan. 
Three hot spots, obtained after domain splitting, are shown as clusters of molecular 
probes: a cluster of 18 probes (cyan); cluster of 16 probes (magenta); cluster of 13 probes 
(gray). An inhibitor (yellow) is superimposed for reference.  
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Figure S1: Population shift between the inactive and active states of Ras-GDP/GTP.  
(Ruth Nussinov, Chung-Jung Tsa  and Hyunbum Jang) 
 
 
Illustration of the population shift phenomenon related to the authorsÕ recent work on oncogenic mutants of 
the KRas4B isoform. Shown is the free energy landscape representing active Ras-GTP and inactive Ras-GDP 
states. Ras can be activated by guanine nucleotide exchange factors that exchange GDP with GTP. The active 
GTP-bound Ras can be inactivated through GTP hydrolysis by GTPase-activating protein (GAP). 
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Figure S2: Allosteric regulation in 
nuclear receptors 
(R.H. Stote, J. Eberhardt, Y. Chebaro, 
A. Dejaegere) 
 
Schematic illustration of the domain 
structure of nuclear receptor proteins. 
This structure comprises the AF-1 N-
terminal domain, DNA binding domain 
(DBD), hinge region, C-terminal ligand 
binding domain (LBD). Sources of 
allosteric signals include ligand binding 
and post-translational modifications, 
which can lead to allosteric signal 
transmission to the DBD affecting DNA binding.  Ligand binding by one receptor can affect ligand binding 
by the second receptor and the DNA sequence can modulate co-activator binding. 
 
Computational tools have been instrumental in understanding allosteric regulation of NRs [1],[2].  An early 
study on the PPARγ LBD identified networks of dynamically coupled amino acids that link the ligand 
binding pocket to the activation helix H12 and the heterodimer interface [3]. A more recently community 
network analysis has been applied to a larger PPAR architecture [4]. 
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Figure S3: The Activation/relaxation MD approach to 
explore allosteric transitions of ligand-gated ion channels 
with atomic resolution: consequences for drug design 
(Marco Cecchini
 
and Jean-Pierre Changeux) 
 
 
Schematic illustration of the activation/relaxation MD approach to 
allosteric transitions in ligand-gated ion channels. Starting from 
the X-ray structure of the bacterial receptor GLIC at pH 4.6 (open), 
a brief equilibration is carried out (a). Then, an instantaneous 
increase in pH is modeled (b), followed by the relaxation towards 
a closed conformation (c). The curves with broken and plain lines 
represent energy landscapes for pH 4.6 and 7.0, respectively. The 
proteinÕs surface is represented in light blue with residues 
changing charge during the pH jump in red. Adapted with permission from Ref. [2].  
 
The all-atom based molecular dynamics activation/relaxation approach described in the main text, relies on 
the hypothesis that allosteric proteins spontaneously populate a number of discrete conformational states in 
reversible equilibrium and that a conformational selection or shift of conformer population takes place upon 
ligand binding/unbinding [1].  In this view, modeling the addition (removal) of the agonist to (from) its 
binding site is expected to trigger a Òvertical excitationÓ of the protein, whose structural relaxation by 
unbiased MD would capture the spontaneous transition to a distinct physiological state..  
 
Lastly, knowledge of the transition path between pairs of physiologically relevant states at atomic resolution 
enables detailed analysis of the dynamics of the ligand-binding pockets. These include sites for orthosteric 
ligands and allosteric modulators, which are most often located at subunit or domains interfaces and typically 
open and close during the functional transitions between resting, active (and desensitized) states. Such 
analyses can be exploited for the rational design of positive or negative allosteric modulators [1], paving the 
way to new pharmacological strategies. 
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Figure S4: Structural Origins of Cryptic 
Binding Sites! !! !! !! !
(Dzmitry Padhorny and Dima Kozakov) !!!  
!
This figure shows the distribution of distances between 
the cryptic binding site and the closest FTsite probe 
cluster with above threshold population in the 
CryptoSite dataset [1]. Analysis is performed based on 
apo structures of the proteins. In the FTsite approach, 
clusters of size 13 and more are considered to be 
binding site predictors, which means that FTsite is able 
to correctly identify the vast majority of known cryptic binding sites. In a similar manner, clusters with more 
than 16 probes pinpoint ÒdruggableÓ binding sites which could be targeted with sufficient affinity, thus 
showing that more than 80% of known cryptic binding sites are druggable. 
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Figure S5: Community network analysis 
elucidating allostery regulation in the 
imidazole glycerol phosphate synthase 
(IGPS) protein 
(Ivan Rivalta) 
 
(A) Tertiary structures of Thermotoga maritima 
IGPS complex from Thermotoga maritima, with 
active site in the HisH protein (gray), allosteric 
site in the HisF protein (yellow) and ammonia 
(blue) channel (gray tube). IGPS catalyzes the 
hydrolysis of glutamine (Gln) at the h active site, 
upon binding of the effector PRFAR to HisF, >25 
 away. The allosteric pathways involve 
secondary structures (in red) on the IGPS right 
side (sideR). (B) Color-coded optimal community 
network of apo (left) and PRFAR-bound (right) 
complexes. The apo communities that contribute 
the most to the PRFAR communities are reported 
in brackets. Connectivity line-widths are 
proportional to the inter-communities total 
betweenness (ITB) with connections relevant to 
IGPS allostery depicted in the right panels. Fully 
and partially conserved residues are indicated with 
(*) and (¥), respectively. Secondary structures are 
in brackets. (C) The allosteric communication 
involves structural changes induced by PRFAR 
binding, affecting the HisF/HisH breathing motion that has been targeted by small molecule inhibitors that 
bind at the interface. Community network analysis [2,3] was applied to derive optimal community networks 
of the apo and effector PRFAR-bound IGPS complexes (B), indicating that effector binding alters 
significantly the information flow between communities (thickness of the links between communities in (B)). 
The findings from these studies have been corroborated by measurements of NMR chemical shifts and were 
shown to be consistent with the expected inactive-to-active allosteric transition in IGPS. This studies have 
stimulated both single site mutagenesis experiments[4] and allosteric inhibitors design [5] (see (C)).  
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Figure S6: Allosteric modulation in 
drug discovery: The PI3Kα 
paradigm 
(Paraskevi Gkeka) 
!
Schematic illustration of the proposed 
allosteric mechanism phosphoinositide 3-
kinase alpha (PI3Kα)[1,2]. 
 
PI3Ks are lipid kinases that play key roles 
in many fundamental biological processes, 
including cell growth, proliferation, 
differentiation, motility, survival, and 
metabolism. Among the different PI3K 
isoforms, PI3Kα is the most important as it 
plays a pivotal role in cell proliferation in 
response to growth factor-tyrosine kinase 
pathway activation [3]. PI3Kα is a 
heterodimer that contains a p110α catalytic subunit and p85α regulatory subunit [1], and is a target of 
particular pharmacological interest for anti-cancer drug development [3,4]. Currently, two PI3Kα inhibitors, 
Alpelisib and MLN1117, are in Phase III trial for patients with HR+/HER2Ðadvanced breast cancer and 
Phase II trial in patients with advanced solid tumors, respectively (https://clinicaltrials.gov, November 2017). 
Despite the advances in targeting the PI3Kα isoform, a major challenge remains because of the highly 
conserved ATP binding sites of lipid kinases. Based on molecular modeling techniques and surface plasmon 
resonance experiments, a multifactorial model of the over-activation mechanism of the most common 
PIK3CA mutant (H1047R), was proposed [1]. Using this model a new binding pocket distinct from the active 
site, and close to residue 1047,was identified. This pocket was further explored for potential allosteric 
modulation of the H1047R PI3Kα mutant [2]. Positional covariance, protein fluctuation analyses showed that 
the main areas involved in protein conformational changes upon ligand binding to the non-ATP pocket are 
the membrane binding domains. PI3Kα mutant activity could therefore, be modulated not in terms of the 
active site activity, but by altering the dynamics of protein-cell membrane interaction and subsequent 
substrate retrieval. Thus, the non-ATP pocket could potentially be used for the discovery of a selective 
inhibitor of protein−membrane interactions tailored for the H1047R mutant protein. Such an inhibitor could 
act by constraining PI3Kα membrane-binding motifs, influencing membrane accessibility and subsequent 
substrate availability, representing a promising alternative or complementary strategy for allosteric PI3Kα 
modulation.! 
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Figure S7: Allosteric modulation of pteridine reductase 1, a member of the short-chain 
dehydrogenases/reductases family 
(Joanna Panecka-Hofman and Rebecca C. Wade)  
 
Displayed are experimental and modeled structures of Pteridine reductase 1 (PTR1, EC 1.5.1.33), a folate 
pathway enzyme unique to trypanosomatid parasites. (A) PTR1 homotetramer structure (T. brucei, pdb: 
3bmc), and the chemical structures of the main substrates and the NADP cofactor, and the reaction catalyzed 
by PTR1 with biopterin as an exemplary substrate (substrate inhibition shown in red). (B) Structures of PTR1 
(a model based on pdb: 1e92) and FabG (pdb: 4ag3).  The proteins are shown in cartoon and molecular 
surface representation and NADP as van der Waals spheres (only heavy atoms are shown). PTR1 catalyzes 
the reduction of folate and biopterin with NADPH cofactor [1]. It belongs to a large family of short-chain 
dehydrogenases/reductases (SDRs), which feature diverse sequences and very diverse functions [3], but have 
a highly conserved Rossmann fold [3].  PTR1 is a potential target for anti-parasitic drugs, but existing 
inhibitors require optimization [2]. Targeting allosteric sites of PTR1 is therefore an attractive alternative.  
PTR1 is inhibited by semi-products of its catalytic reaction (substrate inhibition) (A)) at substrate 
concentration of ~10-mM levels, and may involve an allosteric mechanism [1]. Cooperativity between the 
binding sites is also postulated for other SDR enzymes, including homotetrameric bacterial 3-ketoacyl-[acyl-
carrier-protein] reductase (FabG, B)[4], and allosteric inhibitors binding at the inter-subunit interfaces were 
reported for FabG [5]. The FabG tertiary and quaternary structure is similar to that of PTR1, despite low 
sequence identity (~29% for L. major PTR1 and P. aeruginosa FabG (B)).  The possibility of allosteric 
regulation in PTR1 was investigated using normal mode analysis (NMA), indicating significant concerted 
movements of the substrate loops flanking the active site. In addition, Rotamerically Induced Perturbation 
simulations (RIP [6]), revealed flexibility hot-spots in the PTR1 homotetramer structure, and suggested 
dynamical allosteric couplings between distant protein residues.  
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Figure S8: Allosteric modulation 
of taste GPCRs!
(Antonella Di Pizio and Masha Y. 
Niv) 
 
The Figure illustrates the ligand-
binding sites of sweet 
(TAS1R2/TAS1R3, in orange and 
green), umami (TAS1R1/TAS1R3, in 
blue and green) and bitter (TAS2Rs, 
in violet) taste receptors, members of 
the G-protein coupled receptors 
(GPCRs) family.   
The odorant or olfactory receptors (ORs) represent the largest family of GPCRs, with over 1000 members in 
mice and ~400 in humans. Sweet (elicited by sugars) and umami (elicited by glutamate) taste modalities are 
mediated via TAS1Rs, and bitter (elicited by caffeine, quinine, strychnine and hundreds of other compounds), 
is mediated by the TAS2Rs family that counts 25 subtypes in humans. Only the crystal structures of the 
extracellular VFT regions of the fish Tas1r2/Tas1r3 heterodimer are currently available [1], but iterative 
combinations of simulation and experiment have been successfully used for delineating binding modes of 
tastants, and for predicting additional ligands [2].  TAS1Rs (Class C GPCRs) contain an extracellular VFT as 
an N-terminal domain, linked to the TM domain via a short cysteine-rich (CR) domain. VFT, the orthosteric 
ligand-binding domain, consists of two lobes that can assume an open (inactive) or closed (active) 
conformation. Umami taste is mediated by a heterodimer composed of TAS1R1 and TAS1R3, and sweet is 
sensed by a heterodimer of TAS1R2 and TAS1R3. 
 
The Sweet receptor, TAS1R2/TAS1R3 heterodimer is activated by diverse compounds, ranging from low 
molecular weight sweeteners to sweet proteins. The umami receptor, TAS1R1/TAS1R3 heterodimer, 
specifically responds to glutamate. Integrated computational approaches and mutagenesis studies identified 
the binding site for sugars in the VFT domain of TAS1R2, and of glutamate in the VFT domain of TAS1R1, 
as reviewed in [2]. An allosteric binding site for small molecules has also been identified in the TM domain 
of TAS1R3. Cyclamate and lactisole bind to an allosteric site in the TM domain, and act as allosteric 
enhancer and negative modulators, respectively, for both sweet and umami receptors [2].  In addition, 
multiple binding sites for different ligands have been identified on the sweet taste receptor. For example, 
small agonist molecules, such as sucralose, saccharin, aspartame and neotame, bind to the orthosteric binding 
site in the TAS1R2 VFT domain, but positive allosteric modulators, sweet taste enhancers, were found to 
bind at the entrance of the VFT domain of the TAS1R2 (ligand-entry site).  
 
Allosteric regulation in bitter receptors is less well understood. TAS2Rs are classified as Class A GPCRs, 
although the sequence similarity is very low (13-29% for the TM domains). Despite low sequence identity the 
orthosteric binding pocket of bitter taste receptors coincides with the canonical binding site of Class A 
GPCRs. In addition, an extracellular or vestibular site has been described to be transiently involved in the 
binding process [3]. 
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